Back

Nadia H. Rizkalla

Nadia H. Rizkalla

Professor, Suez Canal University, Egypt

Title: Pap smear screening in a primary care setting in Saudi Arabia

Biography

Nadia H Rizkalla has graduated from Cairo University Medical School in 1976 and completed her Doctoral degree in Community Medicine in a joint program between the University of California at Los Angeles (UCLA) and Suez Canal University (SCU) in Egypt. She has completed her Postdoctoral studies at London School of Hygiene and Tropical Medicine. She was the Chairman of the Department of Community Medicine at the Faculty of Medicine, SCU, and she is currently an Emeritus Professor. She has published more than 20 papers in reputed journals and has been serving as WHO Consultant

Abstract

Objective: To report the findings of an organized Pap smear screening program in a primary care setting and describe the pattern of women’s compliance to screening. Methods: The study was conducted in the Department of Family and Community Medicine at Prince Sultan Military Medical City in Riyadh, Saudi Arabia. The data were the archives of women registered in the Papanicolaou (Pap) smears testing program at the Maternal Care Centers from the start of the program in 2003 to 2010. Results: Of 2184 women, age between 16 and 81 years, 74.1% had their first Pap smear done and 37 (2.4%) had abnormalities. Only 6.7% had their second smear and 5 (3.1%) had abnormalities. Among 23 women who had their third smear, 1 (4.3%) had atypical squamous cells and 1 (4.3%) had Human Papilloma Virus (HPV) changes. In multivariate analysis, woman working status was the most important predictor of her having a Pap smear done along with intake of oral pills and higher parity. Abnormal test finding is predicted by intake of oral contraceptive pills. Conclusion: This study shows low women’s compliance with screening, particularly at the extremes of age and among housewives. Pap smear changes are low and are related to use of contraceptive pills. More effort is needed to increase women's compliance with Pap smear screening guidelines